Status:
COMPLETED
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Knee Osteoarthritis
Lead Sponsor:
Kufa University
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
To assess the efficacy and safety of the Ginkgo biloba extract in patients with Knee OA.
Eligibility Criteria
Inclusion
- patients 40-75 years old with knee OA.
- Grade II and Grade III according to the Kellgrenn-Lawrence (KL) grading system of radiographic OA.
Exclusion
- Pregnancy, breastfeeding
- Liver or renal problems
- Patient taking any drug that might interact with Ginkgo extract (eg. warfarin, etc.)
- patient with cardiovascular or cerebral vascular disorders, uncontrolled diabetes, allergic to ginkgo, recent surgery or hospital admission, \>75 years old.
- Allergic or contraindicated to using NSAIDs
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05398874
Start Date
November 1 2021
End Date
August 1 2022
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Clinic
Najaf, N/A (Outside of US), Iraq, 00964